Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease

被引:14
|
作者
Cui, Jing [1 ]
Zhao, Panxiong [2 ]
Ren, Zhentai [3 ]
Liu, Baoping [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Nucl Med, Zhengzhou, Henan, Peoples R China
[2] Henan Univ, Affiliated Hosp 1, Dept Nucl Med, Kaifeng, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 5, Dept Radiat Oncol, Zhengzhou, Henan, Peoples R China
关键词
F-18-FDG PET; FDG-PET; CANCER; INDEX;
D O I
10.1097/MD.0000000000001356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To assess the clinical value of dual time point imaging (DTPI) fluorine-18fludeoxyglucose (18F-FDG) positron emission tomography (PET)/CT in differentiating malignancy and benign disease of patients with focally increased gastric uptake.Patients who present focally increased 18F-FDG uptake in gastric wall on conventional PET/CT imaging received delayed imaging. PET/CT scans were acquired at 1 and 2hours (early and delayed imaging) after 18F-FDG injection. The maximum standardized uptake value (SUV) was calculated. The SUVmax of the early and delayed imaging acquisition were signed S1 and S2, respectively. The receiver operating characteristic curve (ROC) of the S1, S2, and the retention index (RI) were drawn to find the best cut-off point value for differential diagnosis. Sensitivity, specificity, Youden index, and the area under the curve (AUC) were calculated, respectively.From September 2010 to May 2015, 74 patients (56 male and 18 female; age of 5712 years; range, 32-86 years) referring for areas of focally increased uptake of 18F-FDG in gastric wall received delayed imaging. The S1 was 5.0 +/- 1.4 (range, 1.9-11.3), and S2 was 5.9 +/- 2.7 (range, 1.0-16.3). The SUVmax were increased in 52 patients in delayed imaging, with 85% (44/52 cases) appeared malignant; decreased in 20 patients, and 90% (18/20 cases) were benign; 2 patients of benign had not changed. The change of SUVmax between malignant and benign was significant difference (t=-5.785, P=0.000).Taking the S1, S2, and RI higher than 4.6%, 5.1%, and 13% as positive diagnostic criteria, the sensitivity were 65.2%,87.0%, and 87.0%, respectively; the specificity were 64.3%, 82.1%, and 89.3%; the Youden index were 0.332, 0.693, and 0.770; AUC were 0.635 (95% confidence intervals (95% CI) 0.507-0.764), 0.873 (95% CI, 0.786-0.961), and 0.923 (95% CI, 0.854-0.992).DTPI is more precise to distinct malignant from benign gastric diseases compared with conventional imaging, and it is readily accessible.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Evaluation of dual time point imaging 18F-FDG PET/CT in the diagnosis of gastric disease
    Cui, Jing
    Gao, Yongju
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [2] Value of dual time point 18F-FDG PET imaging for differentiating malignant from benign lesions
    Zhang, Y. X.
    Dong, J. L.
    Wu, Z. J.
    Jia, Q.
    Wei, H.
    Lan, X. L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S153 - S153
  • [3] The Clinical Value of Dual-Time Point 18F-FDG PET/CT for Differentiating Extrahepatic Cholangiocarcinoma From Benign Disease
    Choi, Eun Kyoung
    Yoo, Ie Ryung
    Kim, Sung Hoon
    Hyun, Joo O.
    Choi, Woo Hee
    Na, Sae Jung
    Park, Sonya Youngju
    [J]. CLINICAL NUCLEAR MEDICINE, 2013, 38 (03) : E106 - E111
  • [4] The clinical value of dual time point F-18 FDG PET/CT for differentiating extrahepatic biliary malignancy from benign disease
    Choi, Hyun Su
    Yoo, Ie Ryung
    Choi, Eun Kyoung
    Oh, Jin Kyoung
    Han, Eun Ji
    Park, Young Ha
    Kim, Sung-Hoon
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [5] Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes
    Zhuang, HM
    Pourdehnad, M
    Lambright, ES
    Yamamoto, AJ
    Lanuti, M
    Li, PY
    Mozley, PD
    Rossman, MD
    Albelda, SM
    Alavi, A
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (09) : 1412 - 1417
  • [6] Evaluation of dual-time point 18F-FDG PET/CT imaging to differentiate malignant from benign pulmonary nodules
    Graham, Jess
    Raynor, Brett
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] Dual time point [18F]FDG PET/CT for differentiating benign from malignant musculoskeletal tumors
    D'Abadie, P.
    Gheysens, O.
    Lhommel, R.
    De Roo, A.
    Schubert, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S111 - S111
  • [8] Brown fat uptake of 18F-FDG on dual time point PET/CT imaging
    Rashmizal, Hairil A. R.
    Noraini, A. R.
    Rossetti, C.
    Jalil, Abdul N.
    [J]. SINGAPORE MEDICAL JOURNAL, 2010, 51 (02) : E37 - E39
  • [9] Dual-Time-Point PET/CT with 18F-FDG for Differentiation of Malignant and Benign Lesions
    Ferreira, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S768 - S769
  • [10] Dual-Time-Point 18F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis
    Lu, Hsi-Huei
    Chiu, Nan-Tsing
    [J]. CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : 332 - 334